In breast cancer, a SIRT1-PRRX1-KLF4-ALDH1 circuitry has been identified, in which SIRT1 deacetylases and stabilizes the epithelial-to-mesenchymal-transition inducer, PRRX1, by inhibiting its proteasomal degradation [210]. This evidence concerns the gene SIRT1 and breast cancer.